ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Erectile Dysfunction Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-11Z3168
Home | Market Reports | Health| Reproductive Health
Global Erectile Dysfunction Market Insights and Forecast to 2028
BUY CHAPTERS

Global Erectile Dysfunction Market Research Report 2024

Code: QYRE-Auto-11Z3168
Report
February 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eli Lilly
Pfizer Inc
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Seoul Pharma
Yabang Pharmacy
Petros Pharmaceuticals

Erectile Dysfunction Market Size

The global Erectile Dysfunction market was valued at US$ 4863.9 million in 2023 and is anticipated to reach US$ 8108.8 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.

Erectile Dysfunction Market

Erectile Dysfunction Market

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
Eli Lilly is one of the most important global key manufacturers of erectile dysfunction, holds a share of about 10%, other key players include Teva Pharma and Pfizer, etc. North America is the largest market, occupied for over 40 percent, followed by Europe. In terms of type, tadalafil type is the largest segment, with a share of over 50%, and in terms of sales channels, the hospital pharmacies segment holds a share of over 30 percent.
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction.

Report Scope

The Erectile Dysfunction market size, estimations, and forecasts are provided in terms of sales volume (Million Pill) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erectile Dysfunction market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Erectile Dysfunction Market Report

Report Metric Details
Report Name Erectile Dysfunction Market
Accounted market size in 2023 US$ 4863.9 million
Forecasted market size in 2030 US$ 8108.8 million
CAGR 7.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Sildenafil
  • Tadalafil
  • Others
Segment by Application
  • Hospital Pharmacies
  • Private Clinics
  • Retail Pharmacies
  • E-Commerce (B2B)
  • E-Commerce (B2C)
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Petros Pharmaceuticals, Seoul Pharma, Yabang Pharmacy
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Erectile Dysfunction manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Erectile Dysfunction in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Erectile Dysfunction Market growing?

Ans: The Erectile Dysfunction Market witnessing a CAGR of 7.0% during the forecast period 2024-2030.

What is the Erectile Dysfunction Market size in 2030?

Ans: The Erectile Dysfunction Market size in 2030 will be US$ 8108.8 million.

What is the Eli Lilly, Teva Pharma, Pfizer share in Erectile Dysfunction Market?

Ans: Eli Lilly is one of the most important global key manufacturers of erectile dysfunction, holds a share of about 10%, other key players include Teva Pharma and Pfizer, etc.

What is the Erectile Dysfunction Market share by type?

Ans: In terms of type, tadalafil type is the largest segment, with a share of over 50%, and in terms of sales channels, the hospital pharmacies segment holds a share of over 30 percent.

Who are the main players in the Erectile Dysfunction Market report?

Ans: The main players in the Erectile Dysfunction Market are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Petros Pharmaceuticals, Seoul Pharma, Yabang Pharmacy

What are the Application segmentation covered in the Erectile Dysfunction Market report?

Ans: The Applications covered in the Erectile Dysfunction Market report are Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce (B2B), E-Commerce (B2C)

What are the Type segmentation covered in the Erectile Dysfunction Market report?

Ans: The Types covered in the Erectile Dysfunction Market report are Sildenafil, Tadalafil, Others

1 Erectile Dysfunction Market Overview
1.1 Product Overview and Scope of Erectile Dysfunction
1.2 Erectile Dysfunction Segment by Type
1.2.1 Global Erectile Dysfunction Market Value Comparison by Type (2024-2030)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Erectile Dysfunction Segment by Application
1.3.1 Global Erectile Dysfunction Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Global Erectile Dysfunction Market Size Estimates and Forecasts
1.4.1 Global Erectile Dysfunction Revenue 2019-2030
1.4.2 Global Erectile Dysfunction Sales 2019-2030
1.4.3 Global Erectile Dysfunction Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Erectile Dysfunction Market Competition by Manufacturers
2.1 Global Erectile Dysfunction Sales Market Share by Manufacturers (2019-2024)
2.2 Global Erectile Dysfunction Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Erectile Dysfunction Average Price by Manufacturers (2019-2024)
2.4 Global Erectile Dysfunction Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Erectile Dysfunction, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Erectile Dysfunction, Product Type & Application
2.7 Erectile Dysfunction Market Competitive Situation and Trends
2.7.1 Erectile Dysfunction Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Erectile Dysfunction Players Market Share by Revenue
2.7.3 Global Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Erectile Dysfunction Retrospective Market Scenario by Region
3.1 Global Erectile Dysfunction Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Erectile Dysfunction Global Erectile Dysfunction Sales by Region: 2019-2030
3.2.1 Global Erectile Dysfunction Sales by Region: 2019-2024
3.2.2 Global Erectile Dysfunction Sales by Region: 2025-2030
3.3 Global Erectile Dysfunction Global Erectile Dysfunction Revenue by Region: 2019-2030
3.3.1 Global Erectile Dysfunction Revenue by Region: 2019-2024
3.3.2 Global Erectile Dysfunction Revenue by Region: 2025-2030
3.4 North America Erectile Dysfunction Market Facts & Figures by Country
3.4.1 North America Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Erectile Dysfunction Sales by Country (2019-2030)
3.4.3 North America Erectile Dysfunction Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Erectile Dysfunction Market Facts & Figures by Country
3.5.1 Europe Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Erectile Dysfunction Sales by Country (2019-2030)
3.5.3 Europe Erectile Dysfunction Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Erectile Dysfunction Market Facts & Figures by Country
3.6.1 Asia Pacific Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Erectile Dysfunction Sales by Country (2019-2030)
3.6.3 Asia Pacific Erectile Dysfunction Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Erectile Dysfunction Market Facts & Figures by Country
3.7.1 Latin America Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Erectile Dysfunction Sales by Country (2019-2030)
3.7.3 Latin America Erectile Dysfunction Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Erectile Dysfunction Market Facts & Figures by Country
3.8.1 Middle East and Africa Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Erectile Dysfunction Sales by Country (2019-2030)
3.8.3 Middle East and Africa Erectile Dysfunction Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Erectile Dysfunction Sales by Type (2019-2030)
4.1.1 Global Erectile Dysfunction Sales by Type (2019-2024)
4.1.2 Global Erectile Dysfunction Sales by Type (2025-2030)
4.1.3 Global Erectile Dysfunction Sales Market Share by Type (2019-2030)
4.2 Global Erectile Dysfunction Revenue by Type (2019-2030)
4.2.1 Global Erectile Dysfunction Revenue by Type (2019-2024)
4.2.2 Global Erectile Dysfunction Revenue by Type (2025-2030)
4.2.3 Global Erectile Dysfunction Revenue Market Share by Type (2019-2030)
4.3 Global Erectile Dysfunction Price by Type (2019-2030)
5 Segment by Application
5.1 Global Erectile Dysfunction Sales by Application (2019-2030)
5.1.1 Global Erectile Dysfunction Sales by Application (2019-2024)
5.1.2 Global Erectile Dysfunction Sales by Application (2025-2030)
5.1.3 Global Erectile Dysfunction Sales Market Share by Application (2019-2030)
5.2 Global Erectile Dysfunction Revenue by Application (2019-2030)
5.2.1 Global Erectile Dysfunction Revenue by Application (2019-2024)
5.2.2 Global Erectile Dysfunction Revenue by Application (2025-2030)
5.2.3 Global Erectile Dysfunction Revenue Market Share by Application (2019-2030)
5.3 Global Erectile Dysfunction Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lilly Erectile Dysfunction Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Erectile Dysfunction Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Erectile Dysfunction Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 BaiYunShan General Factory
6.4.1 BaiYunShan General Factory Corporation Information
6.4.2 BaiYunShan General Factory Description and Business Overview
6.4.3 BaiYunShan General Factory Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BaiYunShan General Factory Erectile Dysfunction Product Portfolio
6.4.5 BaiYunShan General Factory Recent Developments/Updates
6.5 S.K. Chemicals
6.5.1 S.K. Chemicals Corporation Information
6.5.2 S.K. Chemicals Description and Business Overview
6.5.3 S.K. Chemicals Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.5.4 S.K. Chemicals Erectile Dysfunction Product Portfolio
6.5.5 S.K. Chemicals Recent Developments/Updates
6.6 Teva Pharma
6.6.1 Teva Pharma Corporation Information
6.6.2 Teva Pharma Description and Business Overview
6.6.3 Teva Pharma Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharma Erectile Dysfunction Product Portfolio
6.6.5 Teva Pharma Recent Developments/Updates
6.7 Dong-A ST
6.6.1 Dong-A ST Corporation Information
6.6.2 Dong-A ST Description and Business Overview
6.6.3 Dong-A ST Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dong-A ST Erectile Dysfunction Product Portfolio
6.7.5 Dong-A ST Recent Developments/Updates
6.8 Petros Pharmaceuticals
6.8.1 Petros Pharmaceuticals Corporation Information
6.8.2 Petros Pharmaceuticals Description and Business Overview
6.8.3 Petros Pharmaceuticals Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Petros Pharmaceuticals Erectile Dysfunction Product Portfolio
6.8.5 Petros Pharmaceuticals Recent Developments/Updates
6.9 Seoul Pharma
6.9.1 Seoul Pharma Corporation Information
6.9.2 Seoul Pharma Description and Business Overview
6.9.3 Seoul Pharma Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Seoul Pharma Erectile Dysfunction Product Portfolio
6.9.5 Seoul Pharma Recent Developments/Updates
6.10 Yabang Pharmacy
6.10.1 Yabang Pharmacy Corporation Information
6.10.2 Yabang Pharmacy Description and Business Overview
6.10.3 Yabang Pharmacy Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Yabang Pharmacy Erectile Dysfunction Product Portfolio
6.10.5 Yabang Pharmacy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Erectile Dysfunction Industry Chain Analysis
7.2 Erectile Dysfunction Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Erectile Dysfunction Production Mode & Process
7.4 Erectile Dysfunction Sales and Marketing
7.4.1 Erectile Dysfunction Sales Channels
7.4.2 Erectile Dysfunction Distributors
7.5 Erectile Dysfunction Customers
8 Erectile Dysfunction Market Dynamics
8.1 Erectile Dysfunction Industry Trends
8.2 Erectile Dysfunction Market Drivers
8.3 Erectile Dysfunction Market Challenges
8.4 Erectile Dysfunction Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Eli Lilly
Pfizer Inc
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Seoul Pharma
Yabang Pharmacy
Petros Pharmaceuticals
List of Tables
    Table 1. Global Erectile Dysfunction Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Erectile Dysfunction Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Erectile Dysfunction Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Erectile Dysfunction Sales (Million Pill) of Key Manufacturers (2019-2024)
    Table 5. Global Erectile Dysfunction Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Erectile Dysfunction Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Erectile Dysfunction Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Erectile Dysfunction Average Price (USD/Pill) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Erectile Dysfunction, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Erectile Dysfunction, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Erectile Dysfunction, Product Type & Application
    Table 12. Global Key Manufacturers of Erectile Dysfunction, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Erectile Dysfunction by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Erectile Dysfunction Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Erectile Dysfunction Sales by Region (2019-2024) & (Million Pill)
    Table 18. Global Erectile Dysfunction Sales Market Share by Region (2019-2024)
    Table 19. Global Erectile Dysfunction Sales by Region (2025-2030) & (Million Pill)
    Table 20. Global Erectile Dysfunction Sales Market Share by Region (2025-2030)
    Table 21. Global Erectile Dysfunction Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Erectile Dysfunction Revenue Market Share by Region (2019-2024)
    Table 23. Global Erectile Dysfunction Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Erectile Dysfunction Revenue Market Share by Region (2025-2030)
    Table 25. North America Erectile Dysfunction Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Erectile Dysfunction Sales by Country (2019-2024) & (Million Pill)
    Table 27. North America Erectile Dysfunction Sales by Country (2025-2030) & (Million Pill)
    Table 28. North America Erectile Dysfunction Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Erectile Dysfunction Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Erectile Dysfunction Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Erectile Dysfunction Sales by Country (2019-2024) & (Million Pill)
    Table 32. Europe Erectile Dysfunction Sales by Country (2025-2030) & (Million Pill)
    Table 33. Europe Erectile Dysfunction Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Erectile Dysfunction Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Erectile Dysfunction Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Erectile Dysfunction Sales by Region (2019-2024) & (Million Pill)
    Table 37. Asia Pacific Erectile Dysfunction Sales by Region (2025-2030) & (Million Pill)
    Table 38. Asia Pacific Erectile Dysfunction Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Erectile Dysfunction Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Erectile Dysfunction Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Erectile Dysfunction Sales by Country (2019-2024) & (Million Pill)
    Table 42. Latin America Erectile Dysfunction Sales by Country (2025-2030) & (Million Pill)
    Table 43. Latin America Erectile Dysfunction Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Erectile Dysfunction Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Erectile Dysfunction Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Erectile Dysfunction Sales by Country (2019-2024) & (Million Pill)
    Table 47. Middle East & Africa Erectile Dysfunction Sales by Country (2025-2030) & (Million Pill)
    Table 48. Middle East & Africa Erectile Dysfunction Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Erectile Dysfunction Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Erectile Dysfunction Sales (Million Pill) by Type (2019-2024)
    Table 51. Global Erectile Dysfunction Sales (Million Pill) by Type (2025-2030)
    Table 52. Global Erectile Dysfunction Sales Market Share by Type (2019-2024)
    Table 53. Global Erectile Dysfunction Sales Market Share by Type (2025-2030)
    Table 54. Global Erectile Dysfunction Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Erectile Dysfunction Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Erectile Dysfunction Revenue Market Share by Type (2019-2024)
    Table 57. Global Erectile Dysfunction Revenue Market Share by Type (2025-2030)
    Table 58. Global Erectile Dysfunction Price (USD/Pill) by Type (2019-2024)
    Table 59. Global Erectile Dysfunction Price (USD/Pill) by Type (2025-2030)
    Table 60. Global Erectile Dysfunction Sales (Million Pill) by Application (2019-2024)
    Table 61. Global Erectile Dysfunction Sales (Million Pill) by Application (2025-2030)
    Table 62. Global Erectile Dysfunction Sales Market Share by Application (2019-2024)
    Table 63. Global Erectile Dysfunction Sales Market Share by Application (2025-2030)
    Table 64. Global Erectile Dysfunction Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Erectile Dysfunction Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Erectile Dysfunction Revenue Market Share by Application (2019-2024)
    Table 67. Global Erectile Dysfunction Revenue Market Share by Application (2025-2030)
    Table 68. Global Erectile Dysfunction Price (USD/Pill) by Application (2019-2024)
    Table 69. Global Erectile Dysfunction Price (USD/Pill) by Application (2025-2030)
    Table 70. Eli Lilly Corporation Information
    Table 71. Eli Lilly Description and Business Overview
    Table 72. Eli Lilly Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2019-2024)
    Table 73. Eli Lilly Erectile Dysfunction Product
    Table 74. Eli Lilly Recent Developments/Updates
    Table 75. Pfizer Corporation Information
    Table 76. Pfizer Description and Business Overview
    Table 77. Pfizer Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2019-2024)
    Table 78. Pfizer Erectile Dysfunction Product
    Table 79. Pfizer Recent Developments/Updates
    Table 80. Bayer Corporation Information
    Table 81. Bayer Description and Business Overview
    Table 82. Bayer Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2019-2024)
    Table 83. Bayer Erectile Dysfunction Product
    Table 84. Bayer Recent Developments/Updates
    Table 85. BaiYunShan General Factory Corporation Information
    Table 86. BaiYunShan General Factory Description and Business Overview
    Table 87. BaiYunShan General Factory Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2019-2024)
    Table 88. BaiYunShan General Factory Erectile Dysfunction Product
    Table 89. BaiYunShan General Factory Recent Developments/Updates
    Table 90. S.K. Chemicals Corporation Information
    Table 91. S.K. Chemicals Description and Business Overview
    Table 92. S.K. Chemicals Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2019-2024)
    Table 93. S.K. Chemicals Erectile Dysfunction Product
    Table 94. S.K. Chemicals Recent Developments/Updates
    Table 95. Teva Pharma Corporation Information
    Table 96. Teva Pharma Description and Business Overview
    Table 97. Teva Pharma Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2019-2024)
    Table 98. Teva Pharma Erectile Dysfunction Product
    Table 99. Teva Pharma Recent Developments/Updates
    Table 100. Dong-A ST Corporation Information
    Table 101. Dong-A ST Description and Business Overview
    Table 102. Dong-A ST Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2019-2024)
    Table 103. Dong-A ST Erectile Dysfunction Product
    Table 104. Dong-A ST Recent Developments/Updates
    Table 105. Petros Pharmaceuticals Corporation Information
    Table 106. Petros Pharmaceuticals Description and Business Overview
    Table 107. Petros Pharmaceuticals Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2019-2024)
    Table 108. Petros Pharmaceuticals Erectile Dysfunction Product
    Table 109. Petros Pharmaceuticals Recent Developments/Updates
    Table 110. Seoul Pharma Corporation Information
    Table 111. Seoul Pharma Description and Business Overview
    Table 112. Seoul Pharma Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2019-2024)
    Table 113. Seoul Pharma Erectile Dysfunction Product
    Table 114. Seoul Pharma Recent Developments/Updates
    Table 115. Yabang Pharmacy Corporation Information
    Table 116. Yabang Pharmacy Description and Business Overview
    Table 117. Yabang Pharmacy Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2019-2024)
    Table 118. Yabang Pharmacy Erectile Dysfunction Product
    Table 119. Yabang Pharmacy Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Erectile Dysfunction Distributors List
    Table 123. Erectile Dysfunction Customers List
    Table 124. Erectile Dysfunction Market Trends
    Table 125. Erectile Dysfunction Market Drivers
    Table 126. Erectile Dysfunction Market Challenges
    Table 127. Erectile Dysfunction Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Erectile Dysfunction
    Figure 2. Global Erectile Dysfunction Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Erectile Dysfunction Market Share by Type in 2023 & 2030
    Figure 4. Sildenafil Product Picture
    Figure 5. Tadalafil Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Erectile Dysfunction Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Erectile Dysfunction Market Share by Application in 2023 & 2030
    Figure 9. Hospital Pharmacies
    Figure 10. Private Clinics
    Figure 11. Retail Pharmacies
    Figure 12. E-Commerce (B2B)
    Figure 13. E-Commerce (B2C)
    Figure 14. Global Erectile Dysfunction Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Erectile Dysfunction Market Size (2019-2030) & (US$ Million)
    Figure 16. Global Erectile Dysfunction Sales (2019-2030) & (Million Pill)
    Figure 17. Global Erectile Dysfunction Average Price (USD/Pill) & (2019-2030)
    Figure 18. Erectile Dysfunction Report Years Considered
    Figure 19. Erectile Dysfunction Sales Share by Manufacturers in 2023
    Figure 20. Global Erectile Dysfunction Revenue Share by Manufacturers in 2023
    Figure 21. The Global 5 and 10 Largest Erectile Dysfunction Players: Market Share by Revenue in 2023
    Figure 22. Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 23. Global Erectile Dysfunction Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 24. North America Erectile Dysfunction Sales Market Share by Country (2019-2030)
    Figure 25. North America Erectile Dysfunction Revenue Market Share by Country (2019-2030)
    Figure 26. United States Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Canada Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Europe Erectile Dysfunction Sales Market Share by Country (2019-2030)
    Figure 29. Europe Erectile Dysfunction Revenue Market Share by Country (2019-2030)
    Figure 30. Germany Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. France Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. U.K. Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Italy Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Russia Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Erectile Dysfunction Sales Market Share by Region (2019-2030)
    Figure 36. Asia Pacific Erectile Dysfunction Revenue Market Share by Region (2019-2030)
    Figure 37. China Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Japan Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. South Korea Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. India Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Australia Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Indonesia Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Thailand Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Malaysia Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Latin America Erectile Dysfunction Sales Market Share by Country (2019-2030)
    Figure 47. Latin America Erectile Dysfunction Revenue Market Share by Country (2019-2030)
    Figure 48. Mexico Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Brazil Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Argentina Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Erectile Dysfunction Sales Market Share by Country (2019-2030)
    Figure 52. Middle East & Africa Erectile Dysfunction Revenue Market Share by Country (2019-2030)
    Figure 53. Turkey Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. UAE Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Global Sales Market Share of Erectile Dysfunction by Type (2019-2030)
    Figure 57. Global Revenue Market Share of Erectile Dysfunction by Type (2019-2030)
    Figure 58. Global Erectile Dysfunction Price (USD/Pill) by Type (2019-2030)
    Figure 59. Global Sales Market Share of Erectile Dysfunction by Application (2019-2030)
    Figure 60. Global Revenue Market Share of Erectile Dysfunction by Application (2019-2030)
    Figure 61. Global Erectile Dysfunction Price (USD/Pill) by Application (2019-2030)
    Figure 62. Erectile Dysfunction Value Chain
    Figure 63. Erectile Dysfunction Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions